Form 4: Goosehead CEO Mark Miller Granted 110,000 Stock Options
Insider Transaction Report
Goosehead Insurance, Inc. CEO Mark Miller was granted 110,000 employee stock options with an exercise price of $77.18, vesting over three years.
Summary
- Mark Miller, President and CEO, Director, and 10% Owner of Goosehead Insurance, Inc. (GSHD), was granted 110,000 employee stock options.
- The options have an exercise price of $77.18 per share.
- The grant date for these options was January 2, 2026.
- The options vest one-third on each of the first, second, and third anniversaries of the grant date, subject to continued employment.
- Accelerated vesting occurs if, within six months following a 'change in control' (as defined in the Issuer's Amended and Restated Omnibus Incentive Plan), employment is terminated without 'cause' or for 'good reason'.
- The options expire on January 2, 2036.
- The transaction was made pursuant to a Rule 10b5-1(c) plan.
Sentiment
Score: 7
Explanation: The grant of stock options to the CEO is generally a positive signal for corporate governance and aligns management's interests with long-term shareholder value. It reflects a commitment to the company's future, though it is a routine compensation event rather than a direct financial performance indicator.
Positives
- The grant of stock options aligns the CEO's financial interests with long-term shareholder value, incentivizing performance.
- The vesting schedule encourages the CEO's continued employment and commitment to the company's sustained growth.
Negatives
- The options do not represent immediate cash value and their ultimate worth depends on the future performance of Goosehead's stock price.
- Potential for future dilution of existing shares if and when these options are exercised.
Risks
- The value of the options is subject to the volatility of Goosehead Insurance, Inc.'s Class A Common Stock price.
- Options may be forfeited if employment is terminated before vesting conditions are met, except under specific change in control scenarios.
- Market conditions could lead to the options becoming 'out-of-the-money' (exercise price higher than market price), rendering them worthless.
Future Outlook
The grant of these long-term incentive options suggests a continued focus on aligning executive compensation with future company performance and shareholder returns over the next decade, with vesting tied to sustained employment and potential acceleration under specific change of control events.
Industry Context
The grant of stock options to a CEO is a standard practice in the insurance and broader financial services industry for executive compensation, aiming to align management incentives with long-term shareholder value creation. The use of a Rule 10b5-1 plan is also a common mechanism for insiders to manage their equity transactions in compliance with insider trading regulations.
Comparison to Industry Standards
- The grant of stock options as a component of executive compensation is a widely adopted practice across publicly traded companies, including those in the insurance sector, such as Progressive Corporation or Allstate Corporation, which frequently utilize equity-based incentives.
- A three-year vesting schedule, with one-third vesting annually, is a common structure for executive equity grants, similar to practices observed at peers like Marsh & McLennan Companies or Aon plc, designed to promote long-term retention and performance.
- The inclusion of accelerated vesting provisions upon a 'change in control' under specific termination conditions is also standard in executive compensation agreements, providing protection for executives in M&A scenarios, consistent with market benchmarks.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Executive Compensation Structure | Grant of 110,000 employee stock options to President and CEO Mark Miller, with a specified vesting schedule and exercise price. | 01/02/2026 | Enhances alignment between executive incentives and long-term shareholder value, promoting retention and performance. The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged trading plan to comply with insider trading laws. |
Stakeholder Impact
- Shareholders: Potential for increased long-term value creation due to aligned executive incentives; potential for future share dilution upon option exercise.
- Employees (CEO): Provides a significant long-term incentive compensation component, tying personal wealth directly to company performance and requiring continued employment for vesting.
Next Steps
- The options will vest in three annual installments, beginning on January 2, 2027, subject to Mark Miller's continued employment.
- Mark Miller may choose to exercise these options at any time after they vest and before their expiration date, subject to company policy and market conditions.
Key Dates
| Date | Description |
|---|---|
| 01/02/2026 | Date of earliest transaction (grant date for employee stock options) |
| 01/02/2027 | First anniversary of grant date, first one-third of options vest (subject to continued employment) |
| 01/02/2028 | Second anniversary of grant date, second one-third of options vest (subject to continued employment) |
| 01/02/2029 | Third anniversary of grant date, final one-third of options vest (subject to continued employment) |
| 01/02/2036 | Expiration date of the employee stock options |
| 01/06/2026 | Signature date of the reporting person's attorney-in-fact |
Keywords
Goosehead Insurance, GSHD, Mark Miller, stock options, executive compensation, Form 4, insider transaction, equity grant, vesting, Rule 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.